The day-to-day operational management is overseen by the Steering Committee (SC)

The SC consists of (since April 2024) :

• Philip Timmerman, also acting as Chairman of the EBF vzw
• Stephen White, GSK
• Kyra Cowan, Merck KGaA
• Matthew Barfield, F. Hoffmann La Roche
• Robert Nelson, BioAgilytix
• Michaela Golob, Nuvisan GmbH